NCT05389956 Identification of Risk Factors for Cardiovascular Disease and Cancer in Korean Population: A Prospective Cohort Study
| NCT ID | NCT05389956 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ulsan University Hospital |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 510,000 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2042-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 510,000 participants in total. It began in 2023-01-01 with a primary completion date of 2042-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cancer and cardiovascular disease are the global leading causes of death. These two disease entities are multifactorial disease that are caused by several factors. The aim of this prospective cohort study was to investigate the status of risk factors profiles and health related behavior in Korean population, and to discover novel risk factors associated with the occurrence of endpoint events.
Eligibility Criteria
Inclusion Criteria: * Men or women aged 19 years and older who underwent a general health screening at the health promotion center of Ulsan University Hospital (Ulsan, Korea) * Subjects have to agree to participate by signing a consent Exclusion Criteria: * Subjects who cannot or reject to sign the consent form.
Contact & Investigator
Sangwoo Park, MD
PRINCIPAL INVESTIGATOR
Ulsan University Hospital
Frequently Asked Questions
Who can join the NCT05389956 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05389956 currently recruiting?
Yes, NCT05389956 is actively recruiting participants. Contact the research team at warya7@naver.com for enrollment information.
Where is the NCT05389956 trial being conducted?
This trial is being conducted at Ulsan, South Korea.
Who is sponsoring the NCT05389956 clinical trial?
NCT05389956 is sponsored by Ulsan University Hospital. The principal investigator is Sangwoo Park, MD at Ulsan University Hospital. The trial plans to enroll 510,000 participants.